Shaanxi Meibang Pharmaceutical Group Co Ltd (605033) — Free Cash Flow Generation Index

Latest as of September 2025: 0.81x

Shaanxi Meibang Pharmaceutical Group Co Ltd (605033) has a Free Cash Flow Generation Index of 0.81x as of September 2025. Free cash flow of CN¥227.48 Million represents 1% of operating cash flow (CN¥281.88 Million). See 605033 net working capital ratio to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

0.81x
Free Cash Flow / Operating CF

Free Cash Flow

CN¥227.48 Million
CNY

Operating Cash Flow

CN¥281.88 Million
CNY

Capital Expenditures

CN¥54.40 Million
CNY

Shaanxi Meibang Pharmaceutical Group Co Ltd Free Cash Flow Generation Index (2017–2024)

Historical FCF Generation Index trend for Shaanxi Meibang Pharmaceutical Group Co Ltd across 7 annual periods. Explore Shaanxi Meibang Pharmaceutical Group Co (605033) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Shaanxi Meibang Pharmaceutical Group Co Ltd (2017–2024)

Year-by-year Free Cash Flow Generation Index for Shaanxi Meibang Pharmaceutical Group Co Ltd. For the full company profile including market capitalisation, see market cap of Shaanxi Meibang Pharmaceutical Group Co .

Year FCG Index Free Cash Flow (CNY) Operating CF Capital Expenditures YoY Change
2024 0.43x CN¥121.59 Million CN¥280.40 Million CN¥158.81 Million ▲ +10.7%
2023 0.39x CN¥131.10 Million CN¥334.79 Million CN¥203.69 Million ▲ +189.1%
2022 0.14x CN¥17.12 Million CN¥126.41 Million CN¥109.29 Million ▼ -23.0%
2020 0.18x CN¥13.17 Million CN¥74.88 Million CN¥61.71 Million ▼ -76.1%
2019 0.74x CN¥94.67 Million CN¥128.45 Million CN¥33.78 Million ▲ +169.8%
2018 -1.06x CN¥-17.90 Million CN¥16.96 Million CN¥34.86 Million ▼ -362.1%
2017 0.40x CN¥11.85 Million CN¥29.41 Million CN¥17.56 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).